Paradromics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
85
- Latest Deal Type
-
Series A
- Investors
-
40
Paradromics General Information
Description
Developer of a data-rate brain-computer interface technology designed to increase the data transmission rate between brains and machines. The company's technology offers high-volume, bidirectional data streaming capabilities between brains and computers, enabling patients with neuro disorders to compensate for the loss of biological connectivity.
Contact Information
Website
www.paradromics.comCorporate Office
- 4030 West Braker Lane
- Suite 250
- Austin, TX 78759
- United States
Corporate Office
- 4030 West Braker Lane
- Suite 250
- Austin, TX 78759
- United States
Paradromics Timeline
Paradromics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series A) | 12-Feb-2025 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series A) | 01-Nov-2023 | Completed | Pre-Clinical Trials | |||
| 9. Later Stage VC (Series A) | 21-Sep-2022 | Completed | Pre-Clinical Trials | |||
| 8. Seed Round | 01-Apr-2022 | Completed | Pre-Clinical Trials | |||
| 7. Grant | 14-Oct-2021 | Completed | Pre-Clinical Trials | |||
| 6. Grant | 10-Sep-2021 | Completed | Pre-Clinical Trials | |||
| 5. Debt - PPP | 14-Apr-2020 | Completed | Pre-Clinical Trials | |||
| 4. Debt - General | 15-Apr-2019 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 04-May-2018 | $7.14M | $7.14M | Completed | Pre-Clinical Trials | |
| 2. Grant | 10-Jul-2017 | $14.2M | Completed | Pre-Clinical Trials |
Paradromics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-1 | ||||||||
| Series A-2 | 35,218,291 | $0.000100 | $0.27 | $0.27 | 1x | $0.27 | 12.8% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Paradromics Comparisons
Industry
Financing
Details
Paradromics Competitors (5)
One of Paradromics’s 5 competitors is EMOTIV, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| EMOTIV | Venture Capital-Backed | San Francisco, CA | ||||
| Neurable | Venture Capital-Backed | Boston, MA | ||||
| NeuroSky | Formerly VC-backed | San Jose, CA | ||||
| ImmersiveTouch | Venture Capital-Backed | Chicago, IL | ||||
| Synchron | Venture Capital-Backed | New York, NY |
Paradromics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Paradromics Patents
Paradromics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12171995-B1 | Methods for improved biocompatibility for human implanted medical devices | Active | 07-Oct-2021 | ||
| US-20210098341-A1 | Microelectrode array and methods of fabricating same | Pending | 30-Sep-2019 | ||
| US-20220110681-A1 | Systems, devices, and methods for tissue layer removal | Pending | 01-Mar-2019 | ||
| EP-3609397-A1 | Low-area, low-power neural recording circuit, and method of training the same | Pending | 14-Apr-2017 | ||
| US-20200046240-A1 | Low-area, low-power neural recording circuit, and method of training the same | Active | 14-Apr-2017 |
Paradromics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Paradromics Investors (40)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Frühstarter Gruppe | Angel Group | Minority | ||
| Kaleida Capital | Venture Capital | Minority | ||
| Leo Lion | Venture Capital | Minority | ||
| NEOM Investment Fund | Venture Capital | Minority | ||
| 15th Rock | Venture Capital | Minority |
Paradromics FAQs
-
When was Paradromics founded?
Paradromics was founded in 2015.
-
Where is Paradromics headquartered?
Paradromics is headquartered in Austin, TX.
-
What is the size of Paradromics?
Paradromics has 85 total employees.
-
What industry is Paradromics in?
Paradromics’s primary industry is Other Healthcare Technology Systems.
-
Is Paradromics a private or public company?
Paradromics is a Private company.
-
What is Paradromics’s current revenue?
The current revenue for Paradromics is .
-
How much funding has Paradromics raised over time?
Paradromics has raised $97.4M.
-
Who are Paradromics’s investors?
Frühstarter Gruppe, Kaleida Capital, Leo Lion, NEOM Investment Fund, and 15th Rock are 5 of 40 investors who have invested in Paradromics.
-
Who are Paradromics’s competitors?
EMOTIV, Neurable, NeuroSky, ImmersiveTouch, and Synchron are competitors of Paradromics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
